vaccines
Novartis opens cell-based flu vaccine plant in US
December 15, 2011Manufacturing and Production Novartis, celll-based, vaccines
Novartis has officially started production at a first-of-its kind cell-based manufacturing facility for influenza vaccines in North Carolina, US. The …
GSK taps Alnylam tech for vaccine production
November 7, 2011Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines
GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …
GSK planning job cuts at Quebec vaccines plant
October 18, 2011Manufacturing and Production Canada, GSK, Quebec, vaccines
GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …
CSL vaccine probe likely to rule out manufacturing errors
September 6, 2011Manufacturing and Production CSL Biotherapies, flu, pharma manufacturing news, vaccines
CSL Biotherapies has said that manufacturing errors were likely not to blame for febrile seizures in children who received its …
Merck vaccines contaminated with plastic, says FDA
August 2, 2011Manufacturing and Production Contamination, Merck & Co, vaccines
Vaccines made by Merck & Co at its West Point facility in Philadelphia, US, have been found to be contaminated …
GSK takes control of China vaccines venture
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines
GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
Arecor and GSK collaborate on vaccine technology
June 15, 2011Manufacturing and Production, Research and Development Arecor, GSK, vaccines
GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
GSK and Merck cut vaccine prices
June 6, 2011Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines
GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …
UNICEF highlights price differences for vaccines
June 2, 2011Sales and Marketing Unicef, developing world, vaccines
A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …
Digital Pharma: Sanofi Pasteur MSD takes Quora approach to vaccines
May 6, 2011Medical Communications Digital Pharma blog, Sanofi Pasteur, vaccines
Sanofi Pasteur MSD is aiming to tackle myths and misconceptions about vaccines with a Quora-like online health information campaign in …
Merck & Co kicks off expansion of Durham vaccines facility
April 26, 2011Manufacturing and Production Merck & Co, manufacturing and production, vaccines
Merck & Co is expanding its vaccines facility in North Carolina, USA, bucking a recent trend at the manufacturer for …
IDT Biologika expands investment in German manufacturing capacity
March 28, 2011Manufacturing and Production Germany, IDT Biologika, vaccines
IDT Biologika has said it plans to invest around 85 million euros in new production facilities and equipment in Germany …
Novartis increases stake in Chinese vaccines firm
March 22, 2011Sales and Marketing China, emerging markets, vaccines
Novartis has continued its expansion into developing markets with the acquisition of a majority stake in a Chinese vaccines company. …
Daiichi recalls contaminated paediatric vaccines
March 15, 2011Manufacturing and Production ActHIB, Daiichi Sankyo, manufacturing compliance, padiatric vaccine recall, recalls, vaccines
Japanese drugmaker Daiichi Sankyo has recalled around 1.3 million doses of the paediatric vaccine ActHIB, manufactured by Sanofi-Aventis, because of …
Dutch government sells off vaccine facility
March 1, 2011Manufacturing and Production Bilthoven, Holland, NVI, Netherlands, Netherlands Vaccine Institute, vaccine manfacturing, vaccine production, vaccines
The Dutch government has put the manufacturing activities and capacity of the Netherlands Vaccine Institute in Bilthoven up for sale, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
